Breast Health

Early diagnosis of inflammatory breast disease and/or cancer means we can develop a new treatment model. Current treatments of surgery , chemotherapy and radiotherapy are invasive, risky emotionally challenging and invite controversial opinions even within the medical community. Some of the post surgical drugs are also not without risk. Tamoxifin increases the risk of ovarian cancer, Evista (raloxifene) the risk of stroke and Herceptin
also invites questionable press.

True early diagnosis of adverse tissue change is now being treated by a nutrigenomic formula regime and more longitudinal research in this area will enhance outcomes in the years ahead. Even for women who are referred for surgery earlier than may have otherwise been possible , the use of thermography as the level one screening can mean simpler surgery and better outcomes.

Thermography is particularly suitable for the pre menopausal breast, for women with very small or dense breast tissue and those with implants. Women who use wheelchairs can be easily screened as they may remain seated.

Mostly Thermography is used for initial screening but is shown in the 4 Hospitals study to be useful in correlating other findings, such as, post mammogram or ultrasound.

All breast screening results are reported on by a specialist Thermologist
If results are suspicious a referral is made for clinical evaluation, usually a diagnostic mammogram. Screening procedures do not diagnose cancer- this is done by pathology testing, usually following a biopsy.

The advances of Digital Thermography for breast screening are:

1. It is a non touch technique therefore painless
2. It is non- invasive – no radiation
3. It allows for early diagnosis of tissue changes which may lead to better long term health options and less invasive treatments.
4. An abnormal digital Thermogram is the single most important marker of high risk for developing future breast cancer, 10 times more significant than a family history of the disease. (Haehnel P et al. 1980) Specialised Breast health management programs reduce this risk.

More information: “Cell Doubling Rates”

Home